Showing results (221-230 of 260) with videos related to
Sort By:
Pageof 26
Australian Journal of Primary Health|January 14, 2025
Implementation of a data-driven quality improvement program in primary care for patients with coronary heart disease: a mixed methods evaluation of acceptability, satisfaction, barriers and enablersNashid Hafiz, Karice Hyun, Qiang Tu, et al.Cell Reports|March 15, 2018
ERRγ Preserves Brown Fat Innate Thermogenic ActivityMaryam Ahmadian, Sihao Liu, Shannon M Reilly, et al.Proceedings of the National Academy of Sciences of the United States of America|May 16, 2023
PHGDH preserves one-carbon cycle to confer metabolic plasticity in chemoresistant gastric cancer during nutrient stressBo Kyung Yoon, Hyeonhui Kim, Tae Gyu Oh, et al.Circulation. Population Health and Outcomes|April 15, 2026
Effectiveness of Data-Driven Quality Improvement on Hospitalizations and Health Outcomes for People With Coronary Heart Disease in Primary Care (QUEL): A Cluster Randomized Controlled Trial With 24-Month Follow-UpJulie Redfern, Nashid Hafiz, Qiang Tu, et al.Cell|February 23, 2019
FXR Regulates Intestinal Cancer Stem Cell ProliferationTing Fu, Sally Coulter, Eiji Yoshihara, et al.Cell|May 15, 2018
Vitamin D Switches BAF Complexes to Protect β CellsZong Wei, Eiji Yoshihara, Nanhai He, et al.European Journal of Pharmacology|October 31, 2006
SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition modelsWarren D Hirst, Tania O Stean, Derek C Rogers, et al.Nature|July 22, 2014
Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizerJae Myoung Suh, Johan W Jonker, Maryam Ahmadian, et al.American Heart Journal|July 21, 2023
Transforming blood pressure control in primary care through a novel remote decision support strategy based on wearable blood pressure monitoring: The NEXTGEN-BP randomized trial protocolSonali R Gnanenthiran, Isabella Tan, Emily R Atkins, et al.The Australian and New Zealand Journal of Psychiatry|November 19, 2019
Wnt receptor gene <i>FZD1</i> was associated with schizophrenia in genome-wide SNP analysis of the Australian Schizophrenia Research Bank cohortXiaoman Liu, Siew-Kee Low, Joshua R Atkins, et al.Pageof 26